Skip to content
Open Data Finder
Open Government Canada

Notice - Prescription Drug List (PDL): Lovastatin

Published by Health Canada | Santé Canada

About this dataset

The purpose of this Notice of Amendment is to announce the revised listing for lovastatin on the Prescription Drug List (PDL). As stated in the Notice of Intent to Amend, posted June 4, 2014, the revision will allow lovastatin to be marketed as a nonprescription product. Only the Human part of the PDL has been revised.

Notice - Prescription Drug List (PDL): Lovastatin · Open Data Finder